NMP 2008
| image1 |
Jinping Dong |
ADVISOR:
Greg Haugstad |
Characterizing Real-Time Drug Release from Engineered Biomedical Coatings
Jinping Dong, Chris Frethem, Greg Haugstad – Characterization
Facility, University of Minnesota
Bob Hoerr, John Foley, Mike Matuszewski – Nanocopoeia, Inc
Judit Puskas – Department of Polymer Science, University of Akron
The ElectroNanospray™ process (Nanocopoeia, Inc) is used to generate
nanoscale drug-polymer composite coatings on medical devices such as coronary
stents in a single-stage process. Drug release
from such coatings is a highly complex and poorly understood process. The
traditional approach of measuring
percent release over time provides researchers with only a grainy snapshot
of the process and is not very informative for directing the engineering
of new coatings to actively control the temporal release of drugs from medical
devices. The purpose of this study was to take a comprehensive approachto
examine drug sequestration, mobility and release from a polymer immersed
in PBS to better understand how to engineer coatings to tailor release profiles
to A model drug delivery system consisting of a polymer matrix (arborescent
polyisobutylene-polystyrene, or arbIBS) and either dexamethasone or sirolimus
was studied by various characterization techniques. Modification of ElectroNanospray
process parameters resulted in surface coatings with rich morphologies that
are revealed by SEM. Atomic Force Microscopy (AFM) and Confocal Raman Microscopy
were employed to monitor the drug release process in situ, through which
the mechanism of the drug-eluting process may be proposed.